A novel injectable chitosan/polyglutamate polyelectrolyte complex hydrogel with hydroxyapatite for soft-tissue augmentation

Dian Yu Ji, Tzong Fu Kuo, Hong Da Wu, Jen Chang Yang, Shang Yang Lee

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

This study demonstrated a chitosan (CS)/polyglutamate (PG) polyelectrolyte complex (PEC) hydrogel combined with spherical hydroxyapatite (HAp) particles as an injectable dermal filler for soft-tissue augmentation. The CS/PG PEC hydrogel with oppositely charged ionic cross-linking, a high gel content, and low degradation rate was introduced as a carrier to achieve high shape and volume stability. An MTT assay indicated that the CS/PG PEC had satisfactory cell biocompatibility. This PEC/HAp hydrogel showed good structural integrity in a PBS solution for up to 60 days. Clinical manageability was indexed by an injection force measurement through sterile 27-gauge needles using a texture analyzer. In an animal study, 0.2 mL of the PEC and PEC/hydroxyapatite (HAp) were implanted within the dorsal dermis of a swine ear. Injected tissue areas were biopsied 2 weeks, and 2 and 6 months after the injection. According to the histomorphometric results, the PEC and PEC/HAp groups showed percentages of retention of the maximum height of the cross-section of about 44% and 73% at 6 months. New collagen was observed in the central position indicating a possible collagenesis effect. These results suggest that this PEC/HAp system can be used as an alternative for soft-tissue augmentation.

Original languageEnglish
Pages (from-to)1123-1130
Number of pages8
JournalCarbohydrate Polymers
Volume89
Issue number4
DOIs
Publication statusPublished - Aug 1 2012

Fingerprint

Polyglutamic Acid
Hydrogel
Chitosan
Durapatite
Polyelectrolytes
Hydroxyapatite
Hydrogels
Tissue
Injections
Force measurement
Structural integrity
Dermis
Biocompatibility
Collagen
Needles
Particles (particulate matter)
Gages
Ear
Fillers
Assays

Keywords

  • Chitosan
  • Dermal filler
  • Hydroxyapatite
  • Polyelectrolyte complex
  • Polyglutamate
  • Soft-tissue augmentation

ASJC Scopus subject areas

  • Organic Chemistry
  • Materials Chemistry
  • Polymers and Plastics
  • Medicine(all)

Cite this

A novel injectable chitosan/polyglutamate polyelectrolyte complex hydrogel with hydroxyapatite for soft-tissue augmentation. / Ji, Dian Yu; Kuo, Tzong Fu; Wu, Hong Da; Yang, Jen Chang; Lee, Shang Yang.

In: Carbohydrate Polymers, Vol. 89, No. 4, 01.08.2012, p. 1123-1130.

Research output: Contribution to journalArticle

@article{3e8accf8cd094829af27ada7eac7d950,
title = "A novel injectable chitosan/polyglutamate polyelectrolyte complex hydrogel with hydroxyapatite for soft-tissue augmentation",
abstract = "This study demonstrated a chitosan (CS)/polyglutamate (PG) polyelectrolyte complex (PEC) hydrogel combined with spherical hydroxyapatite (HAp) particles as an injectable dermal filler for soft-tissue augmentation. The CS/PG PEC hydrogel with oppositely charged ionic cross-linking, a high gel content, and low degradation rate was introduced as a carrier to achieve high shape and volume stability. An MTT assay indicated that the CS/PG PEC had satisfactory cell biocompatibility. This PEC/HAp hydrogel showed good structural integrity in a PBS solution for up to 60 days. Clinical manageability was indexed by an injection force measurement through sterile 27-gauge needles using a texture analyzer. In an animal study, 0.2 mL of the PEC and PEC/hydroxyapatite (HAp) were implanted within the dorsal dermis of a swine ear. Injected tissue areas were biopsied 2 weeks, and 2 and 6 months after the injection. According to the histomorphometric results, the PEC and PEC/HAp groups showed percentages of retention of the maximum height of the cross-section of about 44{\%} and 73{\%} at 6 months. New collagen was observed in the central position indicating a possible collagenesis effect. These results suggest that this PEC/HAp system can be used as an alternative for soft-tissue augmentation.",
keywords = "Chitosan, Dermal filler, Hydroxyapatite, Polyelectrolyte complex, Polyglutamate, Soft-tissue augmentation",
author = "Ji, {Dian Yu} and Kuo, {Tzong Fu} and Wu, {Hong Da} and Yang, {Jen Chang} and Lee, {Shang Yang}",
year = "2012",
month = "8",
day = "1",
doi = "10.1016/j.carbpol.2012.03.083",
language = "English",
volume = "89",
pages = "1123--1130",
journal = "Carbohydrate Polymers",
issn = "0144-8617",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - A novel injectable chitosan/polyglutamate polyelectrolyte complex hydrogel with hydroxyapatite for soft-tissue augmentation

AU - Ji, Dian Yu

AU - Kuo, Tzong Fu

AU - Wu, Hong Da

AU - Yang, Jen Chang

AU - Lee, Shang Yang

PY - 2012/8/1

Y1 - 2012/8/1

N2 - This study demonstrated a chitosan (CS)/polyglutamate (PG) polyelectrolyte complex (PEC) hydrogel combined with spherical hydroxyapatite (HAp) particles as an injectable dermal filler for soft-tissue augmentation. The CS/PG PEC hydrogel with oppositely charged ionic cross-linking, a high gel content, and low degradation rate was introduced as a carrier to achieve high shape and volume stability. An MTT assay indicated that the CS/PG PEC had satisfactory cell biocompatibility. This PEC/HAp hydrogel showed good structural integrity in a PBS solution for up to 60 days. Clinical manageability was indexed by an injection force measurement through sterile 27-gauge needles using a texture analyzer. In an animal study, 0.2 mL of the PEC and PEC/hydroxyapatite (HAp) were implanted within the dorsal dermis of a swine ear. Injected tissue areas were biopsied 2 weeks, and 2 and 6 months after the injection. According to the histomorphometric results, the PEC and PEC/HAp groups showed percentages of retention of the maximum height of the cross-section of about 44% and 73% at 6 months. New collagen was observed in the central position indicating a possible collagenesis effect. These results suggest that this PEC/HAp system can be used as an alternative for soft-tissue augmentation.

AB - This study demonstrated a chitosan (CS)/polyglutamate (PG) polyelectrolyte complex (PEC) hydrogel combined with spherical hydroxyapatite (HAp) particles as an injectable dermal filler for soft-tissue augmentation. The CS/PG PEC hydrogel with oppositely charged ionic cross-linking, a high gel content, and low degradation rate was introduced as a carrier to achieve high shape and volume stability. An MTT assay indicated that the CS/PG PEC had satisfactory cell biocompatibility. This PEC/HAp hydrogel showed good structural integrity in a PBS solution for up to 60 days. Clinical manageability was indexed by an injection force measurement through sterile 27-gauge needles using a texture analyzer. In an animal study, 0.2 mL of the PEC and PEC/hydroxyapatite (HAp) were implanted within the dorsal dermis of a swine ear. Injected tissue areas were biopsied 2 weeks, and 2 and 6 months after the injection. According to the histomorphometric results, the PEC and PEC/HAp groups showed percentages of retention of the maximum height of the cross-section of about 44% and 73% at 6 months. New collagen was observed in the central position indicating a possible collagenesis effect. These results suggest that this PEC/HAp system can be used as an alternative for soft-tissue augmentation.

KW - Chitosan

KW - Dermal filler

KW - Hydroxyapatite

KW - Polyelectrolyte complex

KW - Polyglutamate

KW - Soft-tissue augmentation

UR - http://www.scopus.com/inward/record.url?scp=84861613044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861613044&partnerID=8YFLogxK

U2 - 10.1016/j.carbpol.2012.03.083

DO - 10.1016/j.carbpol.2012.03.083

M3 - Article

VL - 89

SP - 1123

EP - 1130

JO - Carbohydrate Polymers

JF - Carbohydrate Polymers

SN - 0144-8617

IS - 4

ER -